Another study showed that siRNA-mediated knockdown of ATG4B in prostate cancer cells resulted in increased apoptosis, further supporting the notion that inhibition of ATG4B may be beneficial for reducing prostate cancer growth [95]. The gene discussed is ATG4B; the disease is prostate carcinoma.